Reuters
reuters.com
did:plc:jbvnehrrdqoulco4rf5gxg5r
Exclusive: US FDA delays two drug reviews in new voucher program after safety, efficacy concerns reut.rs/3YH1Kly https://reut.rs/3YH1Kly
2026-01-15T15:30:25.932Z
Enable JavaScript to use Bluesky.
Learn more about Bluesky at bsky.social and atproto.com.